Cost-effectiveness analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at low risk of surgical mortality in Sweden
2024

Cost-effectiveness of TAVI vs SAVR for Aortic Stenosis

Sample size: 603 publication Evidence: high

Author Information

Author(s): Konrad Nilsson, Stefan James, Oskar Angerås, Jenny Backes, Henrik Bjursten, Pascal Candolfi, Mattias Götberg, Henrik Hagström, Chiara Malmberg, Niels Erik Nielsen, Archita Sarmah, Magnus Settergren, Tom Bromilow

Primary Institution: Uppsala University, Uppsala, Sweden

Hypothesis

Is transcatheter aortic valve implantation (TAVI) more cost-effective than surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis at low risk of surgical mortality in Sweden?

Conclusion

TAVI with SAPIEN 3 is a cost-effective option compared to SAVR for patients with symptomatic severe aortic stenosis at low risk for surgical mortality in Sweden.

Supporting Evidence

  • TAVI resulted in lifetime costs of 940,541 SEK and 7.16 QALYs per patient.
  • SAVR resulted in lifetime costs of 821,380 SEK and 6.81 QALYs per patient.
  • TAVI offered an incremental improvement of +0.35 QALY per patient.
  • The incremental cost-effectiveness ratio for TAVI was 343,918 SEK per QALY gained.
  • TAVI is expected to be cost-effective at the Swedish WTP threshold of 1,000,000 SEK/QALY.

Takeaway

This study found that a new heart valve procedure called TAVI is cheaper and better for patients than the traditional surgery for a specific group of patients.

Methodology

A two-stage, Markov-based cost-utility model was used, analyzing data from the SWEDEHEART registry and local cost data.

Potential Biases

Data dependency on registry accuracy and potential biases in cost estimations.

Limitations

Results may not be generalizable to all patients with aortic stenosis due to exclusions in the PARTNER 3 trial and potential overestimation of costs.

Participant Demographics

Patients aged 70-80 years with symptomatic severe aortic stenosis and low surgical risk.

Digital Object Identifier (DOI)

10.48101/ujms.v129.10741

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication